Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Informed consent is an unavoidably complicated issue
| The first 150 words of the full text of this article appear below. |
The issue of informed consent within medical
practice, research, and publication is coming increasingly to the fore
as the balance of power in the doctor-patient relationship tips towards patients. Last week Britain's General Medical Council heard a case in
which a paediatric cardiologist was accused of going beyond the consent
that he was given to treat a child. The child died, and he was found
guilty of serious professional misconduct and erased from the medical
register for six months (p 955).1 When, last year, we
published a cluster of articles asking whether we should decline to
publish studies where patients had not given fully informed consent we
prompted a flood of correspondence. We received over 50 letters, most
of them argued with unusual care and clarity. Authors split down the
middle between those who argued that we should always insist on
informed consent (except in very limited circumstances) and those who
a response to recent correspondence Changing the BMJ's position on informed consent would be counterproductive Informed consent
a publisher's duty Trial subjects must be fully involved in design and approval of trials Studies that do not have informed consent from participants should not be published
Read all Rapid Responses